ArticleNature medicine2026

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Marc S Raab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.